Results 111 to 120 of about 3,185 (196)
Movement Disorders, Volume 41, Issue 6, Page 1605-1608, June 2026.
Letizia Santinelli +18 more
wiley +1 more source
Additional file 1 of Two lysosomal genes ATP13A2 and GBA1 interact to drive neurodegeneration
Supplementary Material ...
Gu, Mingxue +17 more
openaire +1 more source
Background: Patients with dementia with Lewy bodies reveal a variable pathology including alpha-synuclein, amyloid-beta, and Tau. Mutations in GBA1 are specifically associated with synucleinopathies.
Machetanz G. +16 more
core +1 more source
The glucocerebrosidase (GCase) encoded by the GBA1 gene hydrolyzes glucosylceramide (GluCer) to ceramide and glucose in lysosomes. Homozygous or compound heterozygous GBA1 mutations cause the lysosomal storage disease Gaucher disease (GD) due to severe ...
Myung Jong Kim +3 more
doaj +1 more source
UPR activation and CHOP mediated induction of GBA1 transcription in Gaucher disease
Chronic presence of mutant, misfolded proteins in the endoplasmic reticulum (ER) initiates ER stress and induces the Unfolded Protein Response (UPR).In Gaucher disease (GD), resulting from mutations in the GBA1 gene, encoding lysosomal acid β ...
Maor, Gali +5 more
core +1 more source
A Global Perspective of GBA1-Related Parkinson’s Disease: A Narrative Review
Parkinson’s disease (PD) is considered to be the second most prominent neurodegenerative disease and has a global prevalence. Glucocerebrosidase (GBA1) gene mutations represent a significant hereditary risk factor for the development of PD and have
Ioanna Pachi +8 more
core +1 more source
Penetrance of Parkinson's disease in GBA1 carriers is depending on the variant severity and polygenic background [PDF]
Background: Heterozygous variants in the GBA1 gene cause Parkinson's disease (PD) with variable penetrance and have been classified into severe, mild, and PD-specific risk variants based on their association with Gaucher's disease (GD; mild and severe ...
Krawitz, Peter +7 more
core +1 more source
Genetic and phenotypic characterization of Parkinson’s disease at the clinic-wide level
Observational studies in Parkinson’s disease (PD) deeply characterize relatively small numbers of participants. The Molecular Integration in Neurological Diagnosis Initiative seeks to characterize molecular and clinical features of every PD patient at ...
Thomas F. Tropea +27 more
doaj +1 more source
Genetic and clinical pharmacology studies in GBA1-associated Parkinson's disease
This thesis focusses on the further unravelling of one of the mechanisms involved in developing Parkinson's disease: the GBA1 gene, encoding the lysosomal enzyme GCase.
Heijer, J.M. den
core

